Late diagnosis of mitral valve myxomatous degeneration and obesity and tachycardia as prognostic complicating cofactors - Case report
DOI:
https://doi.org/10.33448/rsd-v12i7.42570Keywords:
Myxomatous; Degeneration; Ecocardiogram; Valves.Abstract
Myxomatous mitral valve degeneration is among the most common heart diseases in dogs, causing changes in the heart valves that degenerate and progress to atrial ventricular overload. This disease can be treated according to the stage of the disease, ranging from A to D, with subdivisions in stage B to B1 and B2. In this case report we present the late diagnosis of an elderly female dog in stage C, and obesity and tachycardia as complicating cofactors of the disease, will be addressed. Obesity is characterized by the accumulation of adipose tissue, it is associated with genetic and hormonal factors and metabolic disorders that can generate cardiac dysfunction, however, the heart dilates, requires greater effort, increases the heart rate and it becomes impracticable to maintain this HR for a prolonged period. An 8 years-old Shih Tzu female dog, weighing 10,3 Kg, was seen in private practice in a city in the state of Goiás. On clinical examination, she was dyspneic and apathetic, RR 48 mrm, HR 240 bpm, on cardiac auscultation she had a grave V murmur. The echocardiogram showed advanced myxomatous mitral valve degeneration and pulmonary edema. Therapy with furosemide, pimobendan, atenolol, amlodipine and benazepreil, was started, but the patient died. This report aims to show the importance of early diagnosis of the disease and obesity and tachycardia as complicating prognostic cofactors. The dog had a quick diagnosis, but without a timely and desirable drug effect. The necropsy was not authorized for further studies.
References
Aikawa, E., Krenning, G., & Baker, A. H. (2019). Endotelial to mesenchymal transition. Circulation, 104(21), 2525-2532. http://doi.org/10.1016/j.jacc.2018.09.089.
Atkins, C., Bonagura, J., Ettinger, S., Fox, P., Gordon, S., Haggstrom, J., Hamlin, R., & Keene, B. (Chair), Luis-Fuentes, V., &Stepien, R. (2009). Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease. Consensus Statementes of the American College of Veterinary Internal Medicine (ACVIM), p. 1142-1150, 2009.
Boswood, A., Häggström, J., Gordon, S. G., Wess, G., Stepien, R. L., Oyama, M. A., Keene, B. W., Bonagura, J., MacDonald, K. A. & Patteson, M. (2016). Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study – a randomized clinical trial. Journal of Veterinary Internal Medicine, 30(6), 1765-1779. https://doi.org/10.1016/j.asams.2017.03.008.
Chamas, P. P. C., Saldanha, I. R. R., & Costa, R. L. O. (2011). Prevalência da doença degenerativa valvar crônica mitral em cães. Journal of the Health Sciences Institute, 214-7, 2011.
Crysant, S. G. (2019). Pathophysiology and treatment of obesity-related hypertension. The Journal of Clinical Hypertension, 21(5):555-559, 2019.
Cunningham, J. (2011). Tratado de fisiologia veterinária. Guanabara Koogan.
De Francesco, T. C. (2013). Management of cardiac emergencies in small animals. Veterinary Clinnics: Small Animal Practice, 43(4), 817-842. https://doi.org/10.116/j.cvsm.2013.03.012.
Ettinger, S. J., Fedlman, E. C., & Taibo, R. A. (2002). Tratado de medicina interna veterinaria: enfermedades del perro y el gato. Manole.
Fox, P. P. (2012). Pathology of myxomatous mitral valve disease in the dog. Journal of Veterinary Cardiology, 14(1), 103-126. Https://doi.org/10.1016/j.jvc.2012.02.001.
Fox, P. R., Sisson, D. & Moise, S. N. (1999). Textbook of Canine and Feline Cardiology (seconded). W. B. Saunders Company.
Häggström, J., Anderson, Ã. O., Falk, T., Nilsfors, L., Olsson, U., Kresken, J. G., Höglund, K., Rishniw, M., Tidholm, A., & Ljungvall, L. (2016). Effect of body weight on echocardiographic measurements in 19,866 pure-bred cats with or without heart disease. Journal of Veterinary Internal Medicine, 30(5), 1601-1611. https://doi.org/10.1111/jvim.14569.
Kealy, J. K., McAllister, H., & Graham, J. P. (2012). Radiologia e ultrassonografia do cão e do gato. Elsevier Saunders.
Keene, B. W., Atkins, C.E., Bonagura, J.D., Fox P. R., Häggstrom, J., Fuentes, V. L., Oyama, M. A., Rush, J. E., Stepien, R., & Uechi, M. (2019). Acvim consensus Guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. Journal of Veterinary Internal Medicine, 33(3), 1127-1140. https://doi.org/10.1111/jvim.15488. Acesso em: 16 de junho de 2023.
Kim, H. T., Han, S. M., Song, W. J., Kim, B., Choi, M., Yoon, J., & Youn, H.-Y. (2017). Retrospective study of degenerative mitral valve disease in Small-breed dogs: survival and prognostic variables. Journal of Veterinary Science, 18(3), 369. https://doi.org/0.4142/jvs.2017.18.3.369.
King, L. G., & Boag, A. (2007). BSAVA Manual of canine and feline emergency and critical care (Issue Ed. 2). British small veterinary association King, L. G., & Boag, A. (2007). BSAVA manual of canine and feline emergency and critical care (Issue Ed. 2). British small animal veterinary association.
Langhorn, R., & Willesen, J. L. (2016). Cardiac troponins in dogs and cats. Journal of Veterinary Internal Medicine, 30(1), 36-50. https://doi.org/10.1111/jvim.13801.
Lima, G. V., & Ferreira, F. S. (2017). N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review. Veterinary Word, 10(9), 1072. https://doi.org/10.14202/vetworld.2017.1072-1082.
Lopez-Alvarez, J., Elliot, J., Pfeiffer, D., Chang, Y., Martin, M., Moonarmart, W., Hezzell, M. J., & Boswood, A. (2015). Clinical severity score system in dogs with degenerative mitral valve disease. Journal of Veterinary Internal Medicine, 29(2), 575-581. https://doi.org/10.1111/jvim.12544.
Martins, B. L. N. D. (2008). Lesão Degenerativa Crônica da Valva Mitral em canídeos: Epidemiologia e diagnóstico ecocardiográfico – Estudo retrospectivo de 41 casos. Dissertação de mestrado em Medicina Veterinária – Faculdade Técnica de Lisboa. Lisboa, 2008.
Mendes, A. C. R., Sousa, F. G., Oliveira, B.C. S., Miranda G. C., & Kwong, M. A. C., (2023), Fatores de risco associados a obesidade e sobrepeso em cães. Revista. hhtps://doi.org/10.26605/medvet-v17nl-5403.
Meurs, K. M., Friedenberg, S. G., Williams, B., Keene, B. W., Atkins, C. E., Adin, D., & Mackay, T. (2018). Evaluation of genes associated with human myxomatous mitral valve disease in dogs with familial myxomatous mitral valve degeneration. Veterinary Journal, 232,16-19. https://doi.org/10.1016/j.tvjl.2017.12.002
Muzzi, R. A. L., Muzzi, L. A. L., Araújo, R. B., Pena, J. L. B., & Nogueira, R. B. (1999). Diagnóstico ecodopplercardiográfico da fibrose crônica da válvula mitral em cão. Arquivo Brasileiro de Medicina Veterinária e Zootecnia, Belo Horizonte, Dec., 1999.
Olivaes, C. G. (2010). Estudos anatômico e clínico da técnica de anuloplastia valvar mitral por plicatura externa em cães. Dissertação de Mestrado em Cirurgia e Anestesiologia Veterinária – Universidade de Franca. 2010,
OMS, Organização Mundial da Saúde. (2021). Assessing and managing children at primary health-care facilities to prevent oveweigth and obesity in the context of the double burden of malnutrition Disponível em: https://www.who.int/publications/i/item/9789241550123. Acesso em 08 de junho de 2023.
Orton, E. C., Lacerda, C. M. R., & Maclea, H. B (2012). SSignaling pathways in mitral valve degeneration. Journal of Veterinary Cardiology, 14(1), 7-17. https://doi.org/10.1016/j.jvc.2011.12.001.
Oyama, Mark. A, Elliot, C., Loughran, K. A., Kossar, A. P., Castillero, E., Levy, R. J., & Ferrari, G. (2020). Comparative pathology of human and canine myxomatous mitral valve degeneration. 5HT and TGF-B mechanisms. Cardiovascular Pathology, 46(1), 107196. https://doi.org/10.1016/j.carpath.2019.107196.
Oyama, Mark A. (2013). Using cardiac biomarkers in veterinary practice. Veterinary Clinics: Small Animal Practice, 43(6), 1261-1272. https://doi.org/10.1016/j.cvsm.2013.07.010.
Partington, C. et al. (2022). The effect f obesity and subsequent weigth reduction on cardiac structure and function in dogs. BMC Veterinary Research, 18(1):351,2022.
Pedersen, H. D., Lorentzen, K. A., & kristensen, B. (1999). Echocardiographic mitral valve prolapse in cavalier King Charles Spaniels: Epidemiology and prognostic significance for regurgitation. Veterinary Record, 144(2), 315-320. https://doi.org/10.1136/vr.144.12.315
Piantedosi, D. et al. (2020). Effect of a Weight Loss Programo n Biochemical and Immunological Profile, Serum Leptim Levels, and Cardiovascular Parameters in Obese Dogs. Frontiers in Veterinary Science, 7: 398, 2020.
Reinero, C., Visser, L. C., Kellihan, H. B., Masseau, I., Rozanski, E., Clercx, C., Williams, K., Abbott, J., Borgarelli, M., & Scansen, B. A. (2020). ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine, 34(2),549-573. https://doi.org/10.1111/jvim.15725
Rodrigues, L. F., (2011), Métodos de Avaliação Corporal em cães. In Universidade Federal de Goiás, p. 1-34,
Salguero, X. S., Prandi, D., Llabrés-Díaz, F., Manzanilla, E. G., Badiella, L., & Bussadori, C. (2019). Heart to spine measurements to defect. Left atrial enlargement in dogs with mitral insufficiency. Iris Veterinary Journal, 72(1), 1-4. https://doi.org/10.1186/s13620-019-0152-6.
Smith, F. W. K., Tilley, L. P., Oyama, M. A., & Sleeper, M. M. (2015). Manual of Canine and Feline Cardiology. In Elsevier (Ed), Canine Internal Medicine Secrets (fifth edit). http://doi.org/10.1016/B978-156053-629-150009-1.
Terzo, E., Di Marcello, M., McAllister, H., Glazier, B., Lo Coco, D., Locatelli, C., Palermo, V., & Brambilla, P. G. (2009). Echocardiographic assessment of 537 dogs with mitral valve prolapse and leaflet involvement. Veterinary Rdiology & Ultrasound, 50(4), 416-422. https://doi.org/10.1111/j.17410-8261.2009.01559.x.
Tropf, M. et al. (2017). Cardiac and Metabolic Variables in Obese Dogs Journal of Veterinary Internal Medicine, 31 (4):1000-1007.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Camila Souza Coelho; Fabiana Sperb Volkweis
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
